Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer

This commentary refers to the article ‘The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study’, by M. D’Souzaet al., doi:10.1093/eurheartj/ehaa884 and the discussion piece ‘Cardiac events associated with ICI therapy—the devil is in the detail’, by M.S. Ankeret al., doi:10.1093/eurheartj/ehab063.
Source: European Heart Journal - Category: Cardiology Source Type: research